ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Pharma Service Firms Invest In Solid State

by Ann M. Thayer
March 16, 2015 | APPEARED IN VOLUME 93, ISSUE 11

SGS Life Science Services is adding X-ray powder diffraction capabilities at its Lincolnshire, Ill., lab for solid-state analysis of drug compounds. “This investment is in response to growing client demand for extended solid-state characterization testing,” says Mark Rogers, SGS senior vice president in North America. The service will allow clients to study crystallinity and polymorphism under regulatory-compliant conditions. Separately, Freeslate is providing its high-throughput automated equipment to the Center for Intelligent Research in Crystal Engineering in the U.K. and Spain for predictive crystallization studies of polymorphs and cocrystals.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment